Evening Standard
UK · 1 hrs ago
AstraZeneca sees stock market value slump by more than £20bn after drug setback
The FTSE 100 firm found the Wainua drug failed to meet a goal to reduce deaths related to heart disease.
Do you trust Evening Standard?
Sign in to rate
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!